Page last updated: 2024-10-30

kynurenic acid and Amyotrophic Lateral Sclerosis

kynurenic acid has been researched along with Amyotrophic Lateral Sclerosis in 3 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
Meininger, V1
Guillemin, GJ1
Tan, L2
Yu, JT1
Iłzecka, J1
Kocki, T1
Stelmasiak, Z1
Turski, WA1

Reviews

1 review available for kynurenic acid and Amyotrophic Lateral Sclerosis

ArticleYear
The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Aging; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Enzyme Inhibitors; Humans; Hunting

2012

Other Studies

2 other studies available for kynurenic acid and Amyotrophic Lateral Sclerosis

ArticleYear
Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors.
    Central nervous system agents in medicinal chemistry, 2009, Volume: 9, Issue:1

    Topics: Adult; Amyotrophic Lateral Sclerosis; Animals; Brain; D-Aspartic Acid; Functional Laterality; Humans

2009
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.
    Acta neurologica Scandinavica, 2003, Volume: 107, Issue:6

    Topics: Age Factors; Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Chromatography, High Pressur

2003